• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Health and Aging Brain Study-Health Disparities (HABS-HD) methods and partner characteristics.健康与衰老大脑研究-健康差异(HABS-HD)方法及合作伙伴特征
Alzheimers Dement (N Y). 2025 Aug 12;11(3):e70140. doi: 10.1002/trc2.70140. eCollection 2025 Jul-Sep.
2
Racial and ethnic disparities in fecundability: a North American preconception cohort study.生育力方面的种族和族裔差异:一项北美孕前队列研究。
Hum Reprod. 2025 Apr 17. doi: 10.1093/humrep/deaf067.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study.在一个多样化的基于社区的队列中对 Ptau181 进行特征描述:HABS-HD 研究。
J Alzheimers Dis. 2024;100(s1):S63-S73. doi: 10.3233/JAD-240633.
5
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
6
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
7
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.皮质 Tau 正电子发射断层扫描模式在临床前阿尔茨海默病患者中的差异。
JAMA Neurol. 2022 Jun 1;79(6):592-603. doi: 10.1001/jamaneurol.2022.0676.
8
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
9
Are Detailed, Patient-level Social Determinant of Health Factors Associated With Physical Function and Mental Health at Presentation Among New Patients With Orthopaedic Conditions?详细的患者层面的健康社会决定因素是否与新骨科患者就诊时的身体功能和心理健康相关?
Clin Orthop Relat Res. 2023 May 1;481(5):912-921. doi: 10.1097/CORR.0000000000002446. Epub 2022 Oct 6.
10
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.

本文引用的文献

1
Characterization of plasma AT(N) biomarkers among a racial and ethnically diverse community-based cohort: an HABS-HD study.基于社区的种族和民族多样化队列中血浆AT(N)生物标志物的特征:一项HABS-HD研究
Alzheimers Dement (N Y). 2025 Feb 19;11(1):e70045. doi: 10.1002/trc2.70045. eCollection 2025 Jan-Mar.
2
Neuroimaging and biofluid biomarkers across race and ethnicity in older adults across the spectrum of cognition.神经影像学和生物流体生物标志物在认知谱中老年人群体中的种族和民族差异。
Ageing Res Rev. 2024 Nov;101:102507. doi: 10.1016/j.arr.2024.102507. Epub 2024 Sep 19.
3
Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study.在一个多样化的基于社区的队列中对 Ptau181 进行特征描述:HABS-HD 研究。
J Alzheimers Dis. 2024;100(s1):S63-S73. doi: 10.3233/JAD-240633.
4
Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4.在 LEARN 和 A4 研究中,与非代表性少数族裔(RE-URG)相比,血浆 P-Tau217 与种族和民族代表性不足(RE-URG)群体的淀粉样蛋白 PET 的关系。
J Prev Alzheimers Dis. 2024;11(4):831-837. doi: 10.14283/jpad.2024.124.
5
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.淀粉样蛋白和 Tau 预测认知和功能下降在认知正常的老年人:来自 A4 和 LEARN 研究的纵向数据。
J Prev Alzheimers Dis. 2024;11(4):802-813. doi: 10.14283/jpad.2024.122.
6
Top Alzheimer's disease risk allele frequencies differ in HABS-HD Mexican- versus Non-Hispanic White Americans.阿尔茨海默病最高风险等位基因频率在西班牙裔美国人和非西班牙裔美国白人之间存在差异。
Alzheimers Dement (Amst). 2023 Dec 27;15(4):e12518. doi: 10.1002/dad2.12518. eCollection 2023 Oct-Dec.
7
Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.社区居住的墨西哥裔美国人和非西班牙裔白人间轻度认知障碍和痴呆的特征。
J Alzheimers Dis. 2022;90(2):905-915. doi: 10.3233/JAD-220300.
8
Health Disparities in Dementia.痴呆症的健康差异。
Continuum (Minneap Minn). 2022 Jun 1;28(3):872-884. doi: 10.1212/CON.0000000000001088.
9
Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non-Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study.与非西班牙裔白人相比,墨西哥裔美国人中由AT(N)框架导致的神经退行性变有所不同:拉丁裔老年人健康与衰老大脑(HABLE)研究。
Alzheimers Dement (Amst). 2022 Feb 9;14(1):e12267. doi: 10.1002/dad2.12267. eCollection 2022.
10
The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics.拉丁裔老年人健康与衰老大脑(HABLE)研究方法及参与者特征。
Alzheimers Dement (Amst). 2021 Jun 21;13(1):e12202. doi: 10.1002/dad2.12202. eCollection 2021.

健康与衰老大脑研究-健康差异(HABS-HD)方法及合作伙伴特征

Health and Aging Brain Study-Health Disparities (HABS-HD) methods and partner characteristics.

作者信息

Petersen Melissa E, Zhou Zhengyang, Hall James R, Phillips Nicole, Meeker Karin L, Borzage Matthew T, Braskie Meredith N, Clark Alexandra L, Shi Yonggang, Rissman Robert A, Zhang Fan, Vintimilla Raul, Casas Antonio, Rhodes Jill, Barber Robert C, Johnson Leigh, Yaffe Kristine, Toga Arthur W, O'Bryant Sid E

机构信息

Institute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA.

Department of Family Medicine University of North Texas Health Science Center Fort Worth Texas USA.

出版信息

Alzheimers Dement (N Y). 2025 Aug 12;11(3):e70140. doi: 10.1002/trc2.70140. eCollection 2025 Jul-Sep.

DOI:10.1002/trc2.70140
PMID:40799724
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12340423/
Abstract

INTRODUCTION

The Health and Aging Brain Study-Health Disparities (HABS-HD) is an ongoing prospective study aimed at understanding brain health and aging. The current work provides a description of the cohort baseline characteristics and outlines the study methodology.

METHODS

We analyzed available data from  = 1066 non-Hispanic Black (NHB),  = 1425 Hispanic, and  = 1349 non-Hispanic White (NHW) partners who were actively enrolled in HABS-HD. Descriptive statistics are presented for each racial/ethnic group across demographic, medical, and diagnostic characteristics. Differences in select amyloid (A), tau (T), and neurodegenerative (N) biomarkers spanning proteomic and neuroimaging were examined along with groupwise differences for cognitive test performance and select social determinants of health (SDoH) factors.

RESULTS

The characteristics of the cohort revealed significant groupwise differences in age, education, sex, and cognitive diagnosis. Higher rates of cognitive impairment (mild cognitive impairment [MCI] and dementia) were found in NHB and Hispanic compared to NHW partners, despite the latter group being older. There were also higher rates of hypertension and diabetes among NHB and Hispanic compared to NHW partners. Differences were also found across many plasma (A/T[N]) biomarkers and select neuroimaging measures, including meta-region of interest and white matter hyperintensities. Positron emission tomography amyloid positivity rates (but not tau positivity) were found to differ, with higher rates observed among NHW (15% amyloid positivity) compared to NHB (3%) partners. Groups also differed by select SDoH factors, including household income, insurance, having a health-care provider, and Area Deprivation Index. All cognitive measures also revealed groupwise differences.

DISCUSSION

The baseline cohort characteristics for HABS-HD reveal significant group differences spanning demographic, medical, cognitive, and biological factors (including A/T[N] biomarkers), which are all critical to understand as they relate to aging and age-related diseases.

HIGHLIGHTS

The Health and Aging Brain Study-Health Disparities (HABS-HD) cohort baseline characteristics and study methodology were provided.Cohort characteristic differences were found across demographic factors, including age, education, sex, and cognitive diagnosis across the representative groups.Biomarkers for amyloid/tau/neurodegeneration spanning blood and neuroimaging were shown to differ as well across cohort groups.Positivity rates for amyloid positron emission tomography were lower for non-Hispanic Black partners in the cohort compared to non-Hispanic White partners.

摘要

引言

健康与衰老大脑研究——健康差异研究(HABS-HD)是一项正在进行的前瞻性研究,旨在了解大脑健康与衰老。当前工作描述了队列的基线特征,并概述了研究方法。

方法

我们分析了来自积极参与HABS-HD研究的1066名非西班牙裔黑人(NHB)、1425名西班牙裔和1349名非西班牙裔白人(NHW)伴侣的可用数据。针对每个种族/族裔群体,呈现了人口统计学、医学和诊断特征方面的描述性统计数据。研究了蛋白质组学和神经影像学中选定的淀粉样蛋白(A)、tau蛋白(T)和神经退行性变(N)生物标志物的差异,以及认知测试表现和选定的健康社会决定因素(SDoH)因素的组间差异。

结果

队列特征显示,在年龄、教育程度、性别和认知诊断方面存在显著的组间差异。与NHW伴侣相比,NHB和西班牙裔中认知障碍(轻度认知障碍[MCI]和痴呆)的发生率更高,尽管后者年龄更大。与NHW伴侣相比,NHB和西班牙裔中高血压和糖尿病的发生率也更高。在许多血浆(A/T[N])生物标志物和选定的神经影像学测量指标上也发现了差异,包括感兴趣的元区域和白质高信号。发现正电子发射断层扫描淀粉样蛋白阳性率(但tau蛋白阳性率无差异)存在差异,NHW(淀粉样蛋白阳性率为15%)伴侣中的阳性率高于NHB(3%)伴侣。各群体在选定的SDoH因素方面也存在差异,包括家庭收入、保险、是否有医疗保健提供者以及地区贫困指数。所有认知测量指标也显示出组间差异。

讨论

HABS-HD的基线队列特征显示,在人口统计学、医学、认知和生物学因素(包括A/T[N]生物标志物)方面存在显著的组间差异,这些差异对于理解与衰老和年龄相关疾病的关系至关重要。

要点

提供了健康与衰老大脑研究——健康差异研究(HABS-HD)队列的基线特征和研究方法。在人口统计学因素方面发现了队列特征差异,包括年龄、教育程度、性别以及各代表性群体的认知诊断。在整个队列组中,血液和神经影像学中淀粉样蛋白/tau蛋白/神经退行性变的生物标志物也存在差异。与非西班牙裔白人伴侣相比,队列中非西班牙裔黑人伴侣的淀粉样蛋白正电子发射断层扫描阳性率较低。